| References |
| Formal Name |
rel-2-[(1S,3S)-3-hydroxycyclohexyl)]-5-(2-methylnonan-2-yl)phenol |
| Molecular Formula |
C22H36O2 |
| Formula Weight |
332.5 |
| Formulation |
A solution in methanol |
| Purity |
≥98% |
| Stability |
1 year |
| Storage |
-20°C |
| Shipping |
Wet ice
in continental US; may vary elsewhere
|
| SMILES |
O[C@@H]1C[C@@H](C2=CC=C(C(C)(C)CCCCCCC)C=C2O)CCC1
|
Background Reading
Melvin, L.S., Milne, G.M., Johnson, M.R., et al. Structure-activity relationships for cannabinoid receptor-binding and analgesic activity: Studies of bicyclic cannabinoid analogs. Mol Pharmacol 44 1008-1015 (1993).
Compton, D.R., Johnson, M.R., Melvin, L.S., et al. Pharmacological profile of a series of bicyclic cannabinoid analogs: Classification as cannabimimetic agents. J Pharmacol Exp Ther 260(1) 201-209 (1992).
| Size |
Global Purchasing |
| 5 mg |
|
| 10 mg |
|
| 25 mg |
|
Description
(+)-CP 47,497-C8-homolog is a bicyclic cannabinoid (CB) analog that avidly binds the CB2 receptor (Ki = 0.83 nM) and is ten-fold more potent than Δ9-THC in its effects in mice. 12 (±)-3-epi CP 47,497-C8 homolog is a by-product generated in the synthesis of (+)-CP 47,497-C8-homolog. This compound is intended to be used as an analytical standard of (±)-CP 47,497-C8-homolog preparations.
1
Melvin, L.S., Milne, G.M., Johnson, M.R., et al. Structure-activity relationships for cannabinoid receptor-binding and analgesic activity: Studies of bicyclic cannabinoid analogs. Mol Pharmacol 44 1008-1015 (1993).
2
Compton, D.R., Johnson, M.R., Melvin, L.S., et al. Pharmacological profile of a series of bicyclic cannabinoid analogs: Classification as cannabimimetic agents. J Pharmacol Exp Ther 260(1) 201-209 (1992).
|
